Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
D Santos García, JC Martínez Castrillo… - Neurodegenerative …, 2016 - Future Medicine
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
[PDF][PDF] Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
DS García, JCM Castrillo, VP Périz, AS Urgorri, SF Díez… - academia.edu
● Treatment with levodopa-carbidopa intestinal gel (LCIG; Duodopa®, AbbVie, IL, USA)
has demonstrated both efficacy and effectiveness in improving motor complications, motor …
has demonstrated both efficacy and effectiveness in improving motor complications, motor …
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
D Santos García, JC Martínez Castrillo, V Puente Périz… - 2016 - lareferencia.info
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.
MC JC - Neurodegenerative Disease Management, 2016 - europepmc.org
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
DS García, JCM Castrillo, VP Périz… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
Clinical Management of Patients With Advanced Parkinson's Disease Treated With Continuous Intestinal Infusion of levodopa/carbidopa
D Santos García, JC Martínez Castrillo… - Neurodegenerative …, 2016 - Taylor & Francis
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
D Santos García, JC Martínez Castrillo, V Puente Périz… - 2016 - openaccess.uoc.edu
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
[PDF][PDF] Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
DS García, JCM Castrillo, VP Périz, AS Urgorri, SF Díez… - researchgate.net
● Although the time since disease onset does not influence the outcome, we recommend to
avoid unnecessary delay in the start of LCIG therapy, since this therapy provides better …
avoid unnecessary delay in the start of LCIG therapy, since this therapy provides better …
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
DS García, JCM Castrillo, VP Périz… - Neurodegenerative …, 2016 - search.proquest.com
Patients with Parkinson's disease often have a good initial response to dopaminergic
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
therapy but later usually develop motor fluctuations and dyskinesia. In these patients …
[PDF][PDF] Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
DS García, JCM Castrillo, VP Périz, AS Urgorri, SF Díez… - researchgate.net
● Although the time since disease onset does not influence the outcome, we recommend to
avoid unnecessary delay in the start of LCIG therapy, since this therapy provides better …
avoid unnecessary delay in the start of LCIG therapy, since this therapy provides better …